LongeCity Media & Archives / Blog entries

Longevity Meme Newsletter

Mon Dec 31, 2007 4:20 am

LONGEVITY MEME NEWSLETTER

December 31 2007



The Longevity Meme Newsletter is a weekly e-mail containing news, opinions

and happenings for people interested in healthy life extension: making use

of diet, lifestyle choices, technology and proven medical advances to live

healthy, longer lives. To subscribe or unsubscribe from the Longevity Meme

Newsletter, please visit http://www.longevitymeme.org/newsletter/



______________________________



CONTENTS



- What You Have In Common With Naked Mole-Rats

- The Latest Rejuvenation Research

- On Inexorable Technological Progress

- Discussion

- Latest Healthy Life Extension Headlines



WHAT YOU HAVE IN COMMON WITH NAKED MOLE-RATS



What you have in common with naked mole-rats if you're lucky, that is:



http://www.fightaging.org/archives/001382.php



"You might recall that different fatty acid or lipid composition in cell

membranes was floated as a reason for the nine-fold longevity of naked

mole-rats over related rodent species. Plenty of oxidative stress in the

older mole-rats, but little sign of biochemical damage resulting from it -

in comparison to those other rodents long since aged to death, that is.

Better, more damage-resistant building blocks down at the molecular level

might be the cause. A forthcoming Rejuvenation Research paper discusses the

results of a similar consideration of cell membrane differences and

longevity within the human species."



It looks like some of the biochemical differences that may help naked

mole-rats live so much longer than other rodents can also be seen in human

biochemistry. According to this study, the descendants of people who lived

to 90 and beyond tend to have cells that look more mole-rattish in their

membrane construction than people of more short-lived families. It is

fascinating to see real, structural differences down at the lowest level

start to appear as a result of the search for the roots of human longevity.



THE LATEST REJUVENATION RESEARCH



The latest issue of Rejuvenation Research is now available online. Remember

that the journal will become bi-monthly in 2008. Links to scientific papers

of interest and commentary on some of the non-scientific content can be

found in this Fight Aging! post:



http://www.fightaging.org/archives/001379.php



ON INEXORABLE TECHNOLOGICAL PROGRESS



A subtle and unresolved debate often rears its head within the healthy life

extension community:



http://www.fightaging.org/archives/001378.php



"Many people see activism in support of longevity science to be of limited

necessity because they believe, I think, that general advances in

technological capabilities drive entrepreneurial development cycles that

drive public support for new uses. In effect, this is a belief in the

robustness of a free market to explore every possible economically viable

avenue for human betterment, and to leap upon newly viable avenues as soon

as they arise.



"My position is that this is probably the case in the long term. However,

as always, it is easy to point out many economically viable and

technologically possible projects that have not been started, in medicine

or other fields, in the decades since they became viable. In addition to

the economy of the free market, there exist economies of regulation,

attention, understanding and philanthropic support - just because something

is viable does not mean it will happen within your lifetime.



"There of course is the crux of the matter. If we are to benefit from

healthy life extension therapies, from medical technologies capable of

repairing the damage of aging, progress must be rapid. Healthy life

extension through scientific advancement is inevitable - but not for us,

unless we get our act together."



http://www.fightaging.org/archives/001314.php



DISCUSSION



The highlights and headlines from the past week follow below. If you have

comments for us, please do send e-mail to newsletter@longevitymeme.org



Remember - if you like this newsletter, the chances are that your friends

will find it useful too. Forward it on, or post a copy to your favorite

online communities. Encourage the people you know to pitch in and make a

difference to the future of health and longevity!



Reason

reason@longevitymeme.org



______________________________



LATEST HEALTHY LIFE EXTENSION HEADLINES



To view commentary on the latest news headlines complete with links and

references, please visit the daily news section of the Longevity Meme:

http://www.longevitymeme.org/news/



Thoughts on the AGEMAP (December 28 2007)

http://www.grailsearch.org/?q=node/59

Some punchy thoughts on the AGEMAP project by the Grailsearcher: "Databases

are usually quite dull. They are filled with tedious gobs of data like shoe

size, date of birth and other boring tidbits that are meaningless on their

own. Having to work with them on a day to day basis can sometimes makes you

want to bore a hole in your head with a spoon. The AGEMAP database kicks

ass though and I'll tell you why. ... 906 gene expressions were shown to

change with age across the various mouse tissues. Who cares? You do. It

sets the stage for similar human studies and understanding why gene

expressions change will lead to therapies that will very likely extend your

healthy lifespan in the coming decades. Significantly. ... This is the

century where the human race will see significant and perhaps even radical

extensions in lifespan due to research taking place now. Decoding the human

genome was a big step in that direction and the subsequent leaps such as

the AGEMAP database which details specific gene expressions are already

taking place." Unvarnished enthusiasm is a good thing, for it it is

inenvitably the enthusiasts who help to make progress happen.



An Economist's View of Healthy Longevity (December 28 2007)

http://www.overcomingbias.com/2007/12/neglected-pro-l.html

Robin Hanson at Overcoming Bias notes that the prospects for healthy life

extension have "sparked many debates, conferences etc. over the last few

years. The invited participants have naturally been intellectuals who have

published on the topic recently, mainly activists and bioethicists. We

economists have not published on this topic, and so have not been included.

But this is not because we have nothing to say. Instead, no economist has

anything special to say. We can all easily see that standard economic

theory seems to say longer healthy lives are a good thing. So none of us

thinks any of us should get precious academic publication credit for saying

such an obvious thing. As a result, life extension debates ignore economic

theory. ... it still seems to me a shame that observers of this debate can

remain unaware of what standard economic theory seems to say on this

subject."



A Glance At Alzheimer's Immunotherapy (December 27 2007)

http://www.orlandosentinel.com/news/local/...0,3936958.story

As reported in the Orlando Sentinal, immunotherapies aimed at Alzheimer's

disease are reaching late stage clinical trials: "The immunization --

gradually injected into a patient's bloodstream with a needle -- is one of

several experimental treatments that use antibodies to attack what are

called beta-amyloid protein plaques that form in the brains of Alzheimer's

patients. Many scientists think such plaques can cause the disease or its

symptoms. ... It is a phase-three trial, which means it could be the final

step before the drug gets federal approval for more widespread use.

Eventually, the trial will involve 1,600 patients in about 200 centers

worldwide. ... The immunotherapy approach now being tested uses antibodies,

either made by scientists or by the patient's own immune system, to attack

and dissolve the plaques. The drug is administered through the veins in the

arm and repeated every three months to replenish the antibodies. Patients'

progress is charted through tests and brain scans." These first attempts

are not expected to do more than slow progression of the condition. The

next generation of therapies will be much more impressive, judging by

progress in the labs today - but of course the inane and expensive

regulatory hurdles mean it will be a decade before any of it is available,

if at all.



Protein Synthesis and Aging (December 27 2007)

http://pmid.us/18056976

Metabolism, the workings of our cells in concert, is a process of

tremendous complexity. This is why many seemingly important correlations

remain to be explored and understood: "Protein synthesis is a tightly

regulated cellular process that affects growth, reproduction, and survival

in response to both intrinsic and extrinsic cues, such as nutrient

availability and energy levels. A pronounced, age-related decline of the

total protein synthesis rate has been observed in many organisms, including

humans. The molecular mechanisms underlying this decline and their role in

the aging process remain unclear. A series of recent studies in the

nematode, Caenorhabditis elegans, have revealed a novel link between

protein synthesis and aging. Remarkably, these research findings, in their

totality, converge to indicate that reduction of mRNA translation prolongs

life in worms. Signal transduction cascades implicated in aging, such as

the insulin/insulin growth factor-1 pathway, interface with mechanisms

regulating protein synthesis via a battery of key mRNA translation factors.

Are the effects of these pathways on aging mediated, in part, by

alterations in protein synthesis? This is an intriguing possibility in

light of the latest discoveries."



Telomeres, Longevity and Storm Petrels (December 26 2007)

http://pmid.us/18071200

Telomeres shorten over time in mammals, are lengthened by telomerase, and

this all seems to be important for aging, cancer and age-related disease.

But many of the important details are still up for debate, even as

companies are working on telomere-based therapies. This paper caught my eye

as illustrative of the complexities that bedevil any sort of biological

research. Given a brace of storm-petrels, what can you determine about

telomeres and longevity? As it turns out, even the fundamental points are a

challenge: "Given that telomeres generally shorten with age, it was

surprising to find that in a population of a long-lived seabird, Leach's

storm-petrel, telomeres appear to lengthen with age. This unique finding

suggested that the longest-lived individuals are able to elongate

telomeres, an interpretation we call the Elongation Hypothesis.

Alternatively, the Selection Hypothesis states that the longest-lived

individuals start with the longest telomeres and variation in telomere

length decreases with age due to the selective disappearance of individuals

with short telomeres." The Selection Hypothesis wins, but "the oldest

adults also show little or no accumulation of short telomeres over time, a

pattern unknown in other species. Long telomeres are thought to provide a

buffer against cellular senescence, and be generally indicative of genome

stability and overall cell health." Biology is always more complex than

you'd like it to be.



Death For Everyone Before Inequality For Anyone (December 26 2007)

http://www.bepress.com/selt/vol1/iss1/art7/

I was just talking about the "inequality for any is worse than death for

all" meme over at Fight Aging!, though the definitive examination is back

somewhat further in the archives. Here is another example, via Studies in

Ethics, Law, and Technology, demonstrating that the "death for all" school

of thought is sadly thriving: "longevity and immortality research exhibits

the same discourse problems as the other new and emerging technology

discourses, namely that [it] makes light of potential and real social risks

that it tailors to a minority of the world and ignores the marginalized

majority of the world." I see this sort of viewpoint - that we should block

progress at the speartip while the hindmost are brought up to par - as a

fundamental misconception of economics and human nature. Equality is the

mirage that leads to death in the desert. The world works this way in

reality: we can labor and trade to move everyone ahead, benefits for all

and inequalities for all, or we can redistribute what presently exists -

which at best leads to stagnation and no progress, and at worst becomes a

repetition of Soviet era Russia and Eastern Europe. In both cases,

inequality will exist - you can't kill it. The choice is between open

inequality in comparative and advancing wealth or painful inequality in

stagnant, deteriorating poverty, disease and rubble.



A Facebook Group For Ending Aging (December 25 2007)

http://www.facebook.com/group.php?gid=4410586435

By way of a little reminder to folk such as I just how far behind the curve

we are, I recently discovered the existence of a fair-sized and well

maintained Facebook group for the book Ending Aging, the Methuselah

Foundation and Strategies for Engineered Negligible Senescence (SENS)

research. 900 members isn't to be sniffed at; you'll need a Facebook

account to see it, however. As I understand the way Facebook-like social

networks operate, a group is a way to show your affiliation to a cause or

ideal, a repository for links, files and other resources of interest, and a

place for discussion. A web site in miniature, contained with the social

network, in other words, and which can be used in much the same way in

support of advocacy and activist goals. Social networks like Facebook are

one part of the ongoing process of lowering the cost of advocacy, making it

possible for more people to meaningfully support a cause with small

investments of time. When the cost of making a modest difference is close

to zero, everyone who so desires can be a part-time patient advocate for

longevity research. This can only be a good thing.



World Transhumanist Association Pledge Drive (December 25 2007)

http://www.transhumanism.org/match/

From the Transhumanist Declaration: "Humanity will be radically changed by

technology in the future. We foresee the feasibility of redesigning the

human condition, including such parameters as the inevitability of aging,

limitations on human and artificial intellects, unchosen psychology,

suffering, and our confinement to the planet earth." The World

Transhumanist Association (WTA), an organization supportive of healthy life

extension science and advocacy, is presently holding a pledge drive to

match $25,000 before the end of January: "Bill Faloon of Life Extension

Foundation and Brian Cartmell of Cartmell Holdings, LLC, have generously

offered to help us kick off our first fundraising event by matching your

donations up to $25,000 until January 31, 2008. We need 250 members to give

$100 each, so your donations can be doubled. This is a unique opportunity

we cannot afford to miss!" The pledge drive website explains how the funds

will be used to expand the reach of transhumanist ideas.



Evolutionary Effects on Human Life Span (December 24 2007)

http://www.physorg.com/news117456722.html

Theorizing on evolutionary effects and diversity in human life span via

PhysOrg.com: "researchers point out that one characteristic unique to but

common among many pygmy populations is their short lifespan compared to

other humans. With this in mind, the researchers suggest that pygmies

represent the 'fast' extreme of life history strategies, with short stature

being a side effect. ... when I went to the field, and started to

interview them, I noticed the very high mortality rates – really high

compared to any other population. So when we checked that different pygmy

groups followed the same pattern, we thought that these facts should be

linked. Also, life history theory has been used for a long time to

understand body size diversity among mammals, and we thought it should also

apply to the understanding of human diversity ... Because of their short

life expectancies, the researchers speculate that pygmies have had to shift

their reproductive years forward. The average life expectancy at birth for

different pygmy populations ranges from just 16 years to 24 years." We

humans are not immune from the historical environments that have shaped

animal species - and we will extend our own healthy life spans, just as we

are extending the healthy life spans of laboratory animals today.



Aging of the Other Genome (December 24 2007)

http://www.youtube.com/watch?v=wEyguiO4UW0

In this video presentation in the Google Techtalk series, biomedical

gerontologist Aubrey de Grey discusses the role of mitochondrial DNA

(mtDNA) in aging: "Among other things, mitochondria perform the chemistry

of breathing - they extract energy from nutrients by exquisitely regulated

chemical reactions that consume oxygen and create [carbon dioxide]. This

vital function depends on the 13 proteins encoded by the mitochondrial DNA

(mtDNA), as well as on hundreds of proteins that are encoded in our more

famous genome and imported across the mitochondrial surface after

construction in the body of the cell. The mtDNA accumulates mutant,

non-functional variants far faster than our main genome, so 20 years ago

scientists began looking at the idea of putting copies of the 13 genes of

interest into the nucleus after making modifications that would cause them

to be processed by the same 'protein import' machinery that processes the

mitochondrion's many other proteins, thus making the mtDNA itself

superfluous and mutations in it harmless. ... Progress has been very

erratic in the meantime but is now very rapid, partly because of Methuselah

Foundation-funded research. However, this approach may still prove

impossible, so many other, ostensibly simpler ideas - some more promising

than others - have been proposed, and I will describe some of these too."



______________________________



If you have comments for us, please do send e-mail to

newsletter@longevitymeme.org.

Read-only archive. Access follows the preserved publication rules; unavailable historical files are marked where applicable.